Gerber Kawasaki Wealth & Investment Management Ironwood Pharmaceuticals Inc Transaction History

Gerber Kawasaki Wealth & Investment Management

$2.16 Billion
Q3 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$10.86 - $13.95 $21 - $27	-2 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$11.92 - $13.92 $191,864 - $224,056	-16,096 Reduced 99.99%	2 $2,000
Q1 2021 May 07, 2021	SELL	$9.04 - $11.86 $44,060 - $57,805	-4,874 Reduced 23.24%	16,098 $179,000
Q4 2020 Feb 09, 2021	BUY	$9.05 - $12.2 $57,847 - $77,982	6,392 Added 43.84%	20,972 $238,000
Q3 2020 Nov 02, 2020	SELL	$8.99 - $10.74 $13,485 - $16,110	-1,500 Reduced 9.33%	14,580 $131,000
Q4 2019 Feb 06, 2020	SELL	$8.22 - $14.0 $36,003 - $61,320	-4,380 Reduced 21.41%	16,080 $213,000
Q3 2019 Nov 07, 2019	BUY	$8.59 - $10.96 $175,751 - $224,241	20,460 New	20,460 $175,000
Q2 2018 Aug 03, 2018	SELL	$11.83 - $16.2 $121,363 - $166,195	-10,259 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$12.07 - $14.87 $123,826 - $152,551	10,259	10,259 $170,000

Others Institutions Holding IRWD

# of Institutions

238

Shares Held

162M

Call Options Held

11.2M

Put Options Held

9.1K

Black Rock Inc. New York, NY

22.9M
Shares

$79.2 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

22M
Shares

$76.3 Million
0.0% of portfolio
Sarissa Capital Management LP Greenwich, CT

16.4M
Shares

$56.7 Million
16.75% of portfolio
Pacer Advisors, Inc. Malvern, PA

11.3M
Shares

$39 Million
0.11% of portfolio
State Street Corp Boston, MA

9.92M
Shares

$34.3 Million
0.0% of portfolio

View Full List

About IRONWOOD PHARMACEUTICALS INC

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $530M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

More about IRWD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gerber Kawasaki Wealth & Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Gerber Kawasaki Wealth & Investment Management with notifications on news.

Account